为了阐明这种现象是由雌激素还是雄激素引起,或者测试药物是否有任何有益作用,HD Biosciences 提供了成熟的肿瘤转移细胞递送平台和超过 1000 种癌细胞系,用于靶点验证和药效研究。 参考资料:[1].https://www.aacr.org/meeting/aacr-annual-meeting-2024 完整海报获取方法 扫描下方二维码,获得本次药明康德生物学业务平台...
泌尿肿瘤领域重磅研究速递 AACR 年会是癌症领域的重点会议之一,第115届美国癌症研究协会(AACR)年会将于当地时间2024年4月5日至10日在美国圣地亚哥举行。近日大会召开在即,本期小编汇总泌尿肿瘤领域中重磅的【临床试验(Clinical Trials,CT)】和【突破性研究(...
BeiGene, Ltd., a global oncology company, announced the presentation of emerging oncology pipeline data at the American Association for Cancer Research Annual Meeting April 5-10 in San Diego. Multiple trials underscore the potential of tislelizumab-containing ...
The company is currently preparing for IND-enabling studies of STRO-003, which it anticipates completing in the first quarter of 2024. The results from this preclinical data set are being presented today at the AACR Annual Meeting, with deta...
home / conference / american-association-for-cancer-research-annual-meeting-aacrOlaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC Megan Hollasch April 23rd 2024 Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with...
Vanderbilt‐Ingram to Capture Triple Crown of Oncology Leadership at ASCO Meeting: Presidents of ASCO, AACR, AACIdoi:10.1097/01.COT.0000294170.24088.81RosenthalEric TOncology Times